Erratum to ``DY-9760e, a novel calmodulin antagonist with cytoprotective action'' [Eur. J. Pharmacol. 336 (1997) 99-106]

By Sugimura M.   Sato T.   Nakayama W.   Morishima Y.   Fukunaga K.   Omitsu M.   Miyamoto E.   Shirasaki Y.  

European Journal of Pharmacology, Vol. 344, Iss. 1, 1998-02 ,pp. : 111-111

Elsevier

Access to resources Recommend Favorite

DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia

By Sato T.   Morishima Y.   Sugimura M.   Uchida T.   Shirasaki Y.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 117-123

Elsevier

Access to resources Recommend Favorite

Novel antagonist implicates the CB 1 cannabinoid receptor in the hypotensive action of anandamide

By Varga K.   Lake K.   Martin B.R.   Kunos G.  

European Journal of Pharmacology, Vol. 278, Iss. 3, 1995-05 ,pp. : 279-283

Elsevier

Access to resources Recommend Favorite

Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action

By  

Current Drug Targets, Vol. 2, Iss. 3, 2001-09 ,pp. : 285-298

Bentham Science Publishers

Access to resources Recommend Favorite

Prasugrel: a novel platelet ADP P2Y₁₂ receptor antagonist. A review on its mechanism of action and clinical development

By Angiolillo Dominick J   Suryadevara Siva   Capranzano Piera   Bass Theodore A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2893-2900

Informa Healthcare

Access to resources Recommend Favorite